Anticancer activity of organotin(IV) carboxylates

This article provides a critical review of the anticancer activity of organotin(IV) carboxylates in the last five years. Most of the organotin(IV) carboxylates discussed in this review have greater anticancer activity against different cell lines than do the standard drugs. Moreover, some of these organotin(IV) carboxylates have pronounced anticancer activity even against cisplatin-resistive cancer cells. The review also highlights structure-activity relationships. (C) 2014 Elsevier B.V. All rights reserved.